Valuation : Abbott Laboratories

Market Cap 19TCr 17TCr 16TCr 14TCr 27TCr 18,60000Cr 27TCr 1,86500Cr 73TCr 9,38900Cr 73TCr 71TCr 31,13300Cr P/E 2026 *
32.3x
P/E 2027 * 24.9x
Enterprise Value 22TCr 19TCr 18TCr 16TCr 30TCr 20,88800Cr 30TCr 2,09500Cr 82TCr 10,54400Cr 82TCr 80TCr 34,96300Cr EV / Sales 2026 *
4.34x
EV / Sales 2027 * 3.94x
Free-Float
86.16%
Yield 2026 *
2.29%
Yield 2027 * 2.44%
1 day-2.69%
1 week-2.69%
Current month+6.47%
1 month+2.84%
3 months+34.07%
6 months+1.69%
Current year-8.59%
1 week 90.5
Extreme 90.5
93
1 month 84.5
Extreme 84.5
93
Current year 65
Extreme 65
100
1 year 65
Extreme 65
102
3 years 65
Extreme 65
106
5 years 65
Extreme 65
128
10 years 34.75
Extreme 34.75
128
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.69%-2.69% - - 19TCr
+0.79%-3.58%-15.22%+8.28% 19TCr
+1.40%-2.27%-1.70%+11.15% 12TCr
+0.25%+1.25%+10.43%+78.93% 6.15TCr
+0.74%-1.29%-1.79%-32.67% 5.16TCr
-0.25%-1.97%+26.78%+53.20% 5.1TCr
+1.71%-1.65%+20.55%-9.70% 3.43TCr
+1.82%+2.98% - - 3.1TCr
-2.49%-4.42%+36.66%-18.17% 2.37TCr
-0.82%-1.17%-4.67%+17.85% 2.34TCr
Average +0.05%-1.10%+8.88%+13.61% 6.53TCr
Weighted average by Cap. -0.16%-1.86%+0.39%+15.16%

Financials

2026 *2027 *
Net sales 5.03TCr 4.33TCr 4.06TCr 3.71TCr 6.99TCr 4,80800Cr 7.01TCr 48TCr 19TCr 2,42700Cr 19TCr 18TCr 8,04700Cr 5.46TCr 4.71TCr 4.41TCr 4.03TCr 7.59TCr 5,22300Cr 7.62TCr 52TCr 20TCr 2,63600Cr 21TCr 20TCr 8,74200Cr
Net income 623.24Cr 537.04Cr 503.53Cr 459.65Cr 865.91Cr 60TCr 868.67Cr 5.97TCr 2.33TCr 30TCr 2.34TCr 2.29TCr 1LCr 792.44Cr 682.85Cr 640.24Cr 584.44Cr 1.1TCr 76TCr 1.1TCr 7.6TCr 2.96TCr 38TCr 2.98TCr 2.91TCr 1,26800Cr
Net Debt 2.39TCr 2.06TCr 1.93TCr 1.77TCr 3.33TCr 2,28800Cr 3.34TCr 23TCr 8.95TCr 1,15500Cr 8.99TCr 8.79TCr 3,83000Cr 2.1TCr 1.81TCr 1.69TCr 1.55TCr 2.91TCr 2,00300Cr 2.92TCr 20TCr 7.84TCr 1,01100Cr 7.87TCr 7.7TCr 3,35300Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change
28/26/28 CHF 90.50 0.00%
27/26/27 CHF 90.50 -2.69%
26/26/26 CHF 93.00 0.00%
25/26/25 CHF 93.00 0.00%
24/26/24 CHF 93.00 0.00%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
112.47USD
Average target price
120.20USD
Spread / Average Target
+6.87%

Quarterly revenue - Rate of surprise